BioSpace News Archive

Pharm Country

Bristol-Myer Squibb Release: Opdivo Plus Yervoy Combination Delivered Overall Survival Benefit Across PD-L1 Expression Levels in Intermediate- and Poor-Risk Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

The safety profile of Opdivo plus Yervoy was consistent with that of previous reports.

November 7, 2017
·
29 min read
GeoVax Publishes Zika Vaccine Study Results in Nature’s Scientific Reports

The paper published today reports research showing that a single intramuscular dose of GeoVax’s Zika vaccine (GEO-ZM02) provided 100% protection in normal mice challenged with a lethal dose of Zika virus (ZIKV) delivered directly into the brain.

November 7, 2017
·
5 min read
Policy

Collegium Receives FDA Approval for sNDA for Xtampza ER

With approval of the sNDA, the updated label for Xtampza ER includes three main changes.

November 7, 2017
·
10 min read
Policy

Sarepta Therapeutics Announces FDA Clearance of IND for the Company’s PPMO Exon 51 Candidate, SRP-5051

Sarepta to immediately initiate a Phase 1/2a clinical trial in patients with Duchenne muscular dystrophy (DMD) amenable to skipping exon 51.

November 7, 2017
·
8 min read
Business

Evoke Pharma Schedules Conference Call and Webcast for Third Quarter 2017 Financial Results

Evoke will hold a conference call on Tuesday, November 14, 2017 at 4:30 pm ET to discuss the results.

November 7, 2017
·
1 min read
Biotech Beach

Neurelis Expands Worldwide Patent Portfolio With Latest Issuance inn Japan

The patent, when issued, will be in force at least until 2032.

November 7, 2017
·
3 min read
Business

Healthcare Insights Upstart Kenzen Names Jim McDonnell CTO

November 7, 2017
·
2 min read
Business

Kala Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides Business Update

As of September 30, 2017, Kala had cash of $122.0 million compared to $45.5 million as of December 31, 2016.

November 7, 2017
·
10 min read
Business

Co-Diagnostics Manufacturing Joint Venture Breaks Ground in India

The facility is expected to be completed in April 2018, at which time CoSara will have the exclusive Indian manufacturing rights for Co-Diagnostics products.

November 7, 2017
·
2 min read
Business

CPHI to Hold Third Quarter 2017 Earnings Conference Call On Wednesday November 15, 2017 at 8:30 a.m. ET

China Pharma Holdings an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans to hold its third quarter 2017 earnings conference call on Wednesday, November 15, 2017 at 8:30 a.m. ET.

November 7, 2017
·
1 min read